MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Cancer Immunotherapy
    • Retinal Degeneration
  • News & Media
  • Contact Us
MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Cancer Immunotherapy
    • Retinal Degeneration
  • News & Media
  • Contact Us
  •  
  • June 2017

AIVITA Comments on Positive Findings from Asterias’ SCiStar Trial for Spinal Cord Injury

AIVITA Biomedical CEO Hans Keirstead, Ph.D. to Speak at Stem Cell Cures Consortium Conference

AIVITA Biomedical is an Irvine, CA based company focused on the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. We leverage our unique expertise in stem cell growth and directed, high-purity differentiation to develop safe, efficient and economical manufacturing processes for therapeutic development.

Recent News

  • AIVITA Biomedical Raises $12.5 Million in Series B-2 Financing Round and Announces New Board of Directors Appointee
  • AIVITA Biomedical to Present at 2020 BIO CEO & Investor Conference
  • AIVITA Biomedical Completes Patient Recruitment in Phase 2 GBM Trial
  • AIVITA Biomedical to Present at Biotech Showcase 2020
  • ROOT OF SKIN™ Skincare Products Sell Out on Every QVC Japan Show in 2019

Site Navigation

  • About Us
  • Programs
  • News & Media
  • Contact Us
Copyright © 2020 | AIVITA Biomedical, Inc.